Glenmark Pharmaceuticals reports over 1.56% rise in Q3 consolidated net profit

27 Jan 2014 Evaluate

Glenmark Pharmaceuticals has reported results for third quarter ended December 31, 2013.

The company has reported 46.44% fall in its net profit at Rs 58.40 crore for the quarter as compared to Rs 109.03 crore for the same quarter in the previous year. Total income from operations of the company decreased by 2.30% at Rs 543.16 crore for quarter under review, as compared to Rs  555.94 crore for the quarter ended December 31, 2012.

On the consolidated basis, the group has reported modest 1.56% rise in its net profit at Rs 216.23 crore for the quarter as compared to Rs 212.91 crore for the same quarter in the previous year. Total income from operations of the company has increased by 15.87% at Rs 1606.83 crore for quarter under review as compared to Rs 1386.76 crore for the quarter ended December 31, 2012.

Glenmark Pharma Share Price

1544.40 -48.50 (-3.04%)
10-Jan-2025 15:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1774.40
Dr. Reddys Lab 1354.25
Cipla 1469.90
Lupin 2190.00
Zydus Lifesciences 1006.85
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.